Putting people at the heart of it all!

Putting people at the heart of it all!

February 18, 2017

It would be easy to dismiss the importance of a microscope slide in the pathology laboratory, after all, put simply it is a flat piece of glass.

Trajan Scientific and Medical (Trajan) believes it is much much more than this, and invite pathology laboratories to work with our range of Trajan microscope slides to make a real difference to their workflow.

At the heart of Trajan is our belief in improving the wellbeing of people. This translates into quality products that do not compromise on performance at any cost.

Understanding the affect that the surface coating functionality has on the performance of a slide, and impact on diagnosis is central to Trajan’s adhesive microscope slides portfolio. 

Breast cancer diagnosis in particular can benefit from the Trajan Series 2 adhesive microscope slides, that have a specialized coating in tandem with reduced background staining, provide improved tissue section adherence and extensibility.

View our range to find out how Trajan’s microscope slides can assist with better diagnosis, improved efficiency and workflow for your pathology laboratory.

Media contact information
Trajan Scientific and Medical
media@trajanscimed.com
+44 (0) 1244 403 100




Also in News

Trajan completes ISO 9001 recertification
Trajan completes ISO 9001 recertification

July 14, 2021

Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.

Read More

Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth
Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth

May 17, 2021

Global analytical science and device company Trajan Group Holdings Limited (Trajan or the Company) has launched a $90 million IPO to support the next phase of accelerated growth.

Read More

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More